Royal Canin Expands Therapeutic Portfolio with Fresh Veterinary Diets
Event summary
- Royal Canin launched its first fresh therapeutic diet portfolio for dogs on July 14, 2026.
- The new diets are available exclusively through veterinarians and target specific health conditions like gastrointestinal issues, food sensitivities, and reduced appetite.
- The portfolio includes three specialized formulas: Gastrointestinal Low Fat, Selected Protein Pork, and Appetite Stimulation.
- Royal Canin positions the launch as a response to growing demand for fresh feeding approaches in veterinary medicine.
The big picture
Royal Canin's launch reflects the broader trend of premiumization in pet care, where fresh and specialized diets are increasingly seen as essential for managing chronic conditions. The move also underscores Mars Incorporated's strategy of leveraging its veterinary networks to drive product adoption. With pet owners growing more discerning about nutrition, Royal Canin aims to solidify its position as a trusted provider of science-backed therapeutic solutions.
What we're watching
- Market Adoption
- How quickly veterinarians and pet owners will embrace the fresh therapeutic diets as a premium offering.
- Competitive Response
- Whether competitors like Hill's Pet Nutrition or Purina will accelerate their own fresh food initiatives in response.
- Regulatory Alignment
- The extent to which Royal Canin can leverage ACVIM-endorsed guidance to differentiate its therapeutic claims.